drugset / Trial / NCT00853606
Long-Term Safety and Efficacy Study of Avanafil in Men With Erectile Dysfunction
NaSingle-groupOpen-labelTreatment
Summary
This open-label study is being conducted to evaluate the long-term safety, tolerability, and efficacy of avanafil in men with mild to severe erectile dysfunction. Approximately 400 subjects will be enrolled and treated with avanafil for up to 52 weeks.
Timeline
- Start
- 2009-03
- Primary completion
- 2010-04
- Completion
- 2010-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Avanafil | Small molecule | 50 mg | — |
| Subject | Avanafil | Small molecule | 100 mg | — |
| Subject | Avanafil | Small molecule | 200 mg | — |